Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients ...

A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...

Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition and ...

Compared to Sotyktu (deucravacitinib), which was approved by the FDA for plaque psoriasis in 2022 and brought in sales of more than $200 million in the first nine months of this year, zasocitinib is ...

In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...

The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to challenge Bristol Myers Squibb’s Sotyktu.

NB-UVB phototherapy may restore adalimumab efficacy in chronic plaque psoriasis after treatment failure. Learn more about ...

And the most recent article came out of JAMA in 2024, and they found that for every 1 g increase in urinary sodium, you ...

Coal tar is mainly the thick, black, liquid byproduct of hot coal without air, which produces coal gas and other chemicals ...